Navigation Links
Who will recover spontaneously from hepatitis C virus infection
Date:8/29/2007

More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or liver cancer. Since there is no cure for chronic hepatitis C, nor is there any approved vaccine for this virus, hepatitis C is currently a major health problem worldwide.

Twenty to fifty percent of HCV infected patients recovers spontaneously. The hepatitis C patients and their relatives like to know if his/her infection would fall into the category for self recovery.

A research article to be published on August 21 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Mihm from Georg-August-Universitt spent more than 8 years working with a cohort of 67 patients who spontaneously recovered from HCV infection. In addition to these, the researchers included a similar number of patients with chronic HCV infection. Large sample size allowed these investigators to obtain results with great statistical significance, and to draw very reliable conclusions.

One conclusion reported by the investigators is, patients who self recovered usually have lower levels of HCV antibody. Thus patients with lower HCV antibody titer may have a brighter clinical outcome. However, for a practical standard to be established to define a low HCV antibody titer, more effort is needed by investigators in the future.

Another interesting conclusion reached by these investigators is, co-infection by hepatitis B virus (HBV) is associated with a higher possibility of self recovery. The investigators suggested that the infection of HBV interferes with the HCV replication, which would finally lead to virus eradiacation.. HCV patients co-infected by hepatitis A virus also have a better chance of self recovery, possibly by a similar mechanism.

Active iv drug users are less likely to self recover
'/>"/>

Contact: Lixin Zhu
wjg@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
2. Dinosaur DNA? New Patent Covers Degraded DNA recovery
3. Bone Density Recovers After Teens Stop Injected Contraceptive
4. U-M team recovers ancient whale in Egyptian desert
5. Low oxygen likely made Great Dying worse, greatly delayed recovery
6. Tsunami-damaged coral reefs should be left to recover naturally, say scientists
7. Combination therapy leads to partial recovery from spinal cord injury in rats
8. Study shows eutrophic lakes may not recover for a millennium
9. Time and money make a difference in endangered species recovery
10. Adult stem cells aid recovery in animal model of cerebral palsy
11. Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , REDWOOD SHORES, Calif. and PALM...mmunication Intelligence Corporation ("CIC") (OTC ...ronic signature solutions for business process aut...zed leader** in biometric signature verification a...nternational Electronic Document Management (EDM) ...
(Date:12/2/2009)..., Single-walled nanotubescylinders of carbon about...r potential applications such as ultrastrong fiber...gen storage components for fuel cells. Thanks to a...stitute of Standards and Technology (NIST) and fiv...e list: detection and destruction of an aggressive...
(Date:12/2/2009)..., A scientist from the University of Salamanca and...presence of predators affects the behaviour of Ac...m the Negev Desert in the Near East. According to ... mobile and different prey if they are under press...d predicted this result, but until now there had b...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Lizards change their diet to avoid predators 2Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference 5940 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 2MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 3Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 14697 1Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 14697 2
...n Molecular Biology Organization (EMBO) announced ... young researchers as the 2007 beneficiaries of it...h year since 2000, the programme identifies and su.... Recipients receive academic, practical and finan... independent careers. , Selected by EMBO Members...
...t. 22 Emphysema patients whose lungs are implante...l valve experience significantly improved measures...e, University of Pittsburgh School of Medicine res...CHEST 2007, the annual meeting of the American Col...inue through Thursday, Oct. 25, at the McCormick P...
...en elderly nursing home residents contract pneumon...Simin Nikbin Meydani, DVM, PhD of the Jean Mayer U...fts University and colleagues report that maintain...ay help reduce the risk of pneumonia development i...rs that daily zinc intake can help nursing home re...
Other Biology News:18 young scientists join EMBO Young Investigator network 2Endobronchial valve significantly improves emphysema 2Zinc may reduce pneumonia risk in nursing home elderly 2
(Date:12/2/2009)...c. 2 S*BIO Pte Ltd today announced...or, SB1518, at The American Society of Hematology ... ,, Data will be presented on the clinical resu...18 detailing its safety, tolerability and pharmaco...vels ranging from 100 to 600 mg. These doses were ...
(Date:12/2/2009)...cientist, a leading scientific magazine covering t...e “Intelligent” EMCCD camera fourth am...ons of 2009. , (PRWEB) De... from Photometrics ®, a designer and manufac...r the life sciences, was ranked fourth among The S...
(Date:12/1/2009).... 1 Reportlinker.com announces tha... catalogue: ,, Industrial Enzymes - A Global M...0164431/Industrial-Enzymes---A-Global-Market-Repor...opoly with few strong players and a host of small ... competition and commoditization characterize the ...
(Date:12/1/2009)... 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, as t...hina-based Contract Research,Organization (CRO), t...,Technology Fast 50 China, ranking 3rd on the list...na. The award is a testament to ChemPartner,s outs...8. , The results of the 2009 Deloitte Tec...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...ed corticosteroid inhaler approved ... Aug. 19 Schering-Plough,Corporation (NYSE: SGP ...0,mcg (mometasone furoate inhalation powder) is no...ndicated for the maintenance treatment of asthma a...ge and older, and is the,first and only once-daily...
...c., a,leader in human embryonic stem cell derived ... an exclusive worldwide technology licensing agree...ation that will enable the,company to commercializ...ity of Georgia., (Logo: http://www.newscom.com/c...rms of the agreement, ArunA has acquired an exclus...
... ,endometrial regenerative cells, (ERCs) are capab...dvanced peripheral artery disease. A study publish...f Translational Medicine demonstrates that when ci...tions, circulation and functionality were restored... peripheral artery disease, causes approximately 1...
Other Biology Technology:Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 2Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 3Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 4Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 5Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 6Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 7Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 8ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells 2Limbs saved by menstrual blood stem cells 2
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
... can provide custom microplate coating using advan...g equipment that dispenses and washes a variety of...any lot size of the following formats (with a volu...ips, 96 well microplate, 384 well microp...
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Coating Solution Concentrate Kit from KPL
Biology Products: